• Теги
    • избранные теги
    • Компании627
      • Показать ещё
      Разное184
      • Показать ещё
      Страны / Регионы88
      • Показать ещё
      Международные организации3
      Издания7
      Сферы3
      Люди18
      • Показать ещё
      Формат1
      Показатели5
Thermo Fisher
02 февраля, 17:30

The Zacks Analyst Blog Highlights: Johnson & Johnson, PayPal, Thermo Fisher, Celgene and American Airlines

The Zacks Analyst Blog Highlights: Johnson & Johnson, PayPal, Thermo Fisher, Celgene and American Airlines

01 февраля, 23:17

Top Research Reports for February 1, 2017

Top Research Reports for February 1, 2017

31 января, 16:58

Thermo Fisher (TMO) Q4 Earnings Beat, Organic Sales Flat

Thermo Fisher Scientific, Inc. (TMO) reported better-than-expected fourth-quarter and full-year 2016 earnings results.

31 января, 15:42

Thermo Fisher (TMO): Tops Q4 Earnings, Misses Revenues

Thermo Fisher (TMO) has posted earnings which has beaten the Zacks Consensus Estimate but its revenues missed the mark.

Выбор редакции
31 января, 01:23

4 Stocks with Great Earnings Charts

Companies that beat nearly every quarter are earnings all-stars.

30 января, 15:06

Medical Products Stocks' Earnings on Jan 31: ZBH, TMO, ABC

Let's take a look at the major Medical Product stocks slated to release their earnings results on tomorrow.

Выбор редакции
18 января, 16:51

Thermo Fisher Scientific started at buy with $163 stock price target at Deutsche Bank

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

18 января, 15:40

Will Thermo Fisher (TMO) Beat Earnings Estimates in Q4?

Thermo Fisher Scientific, Inc. (TMO) is scheduled to report fourth-quarter and full-year 2016 results before the opening bell on Jan 31.

13 января, 02:34

Top Research Reports for January 12, 2017

Top Research Reports for January 12, 2017

Выбор редакции
05 января, 04:08

Chief Justice Roberts Will Sit Out Patent Case Over $175,000 Stock Conflict

WASHINGTON ― Chief Justice John Roberts will no longer participate in a patent dispute at the Supreme Court involving a unit of Thermo Fisher Scientific Inc., after he realized he owns about $175,000 of stock in the company, the court said on Wednesday. The eight-justice court is weighing whether genetic-testing kits made by Thermo Fisher-owned Life Technologies Corp infringed upon patents held by Promega Corp. In a letter issued on Wednesday, Scott Harris, the clerk of the court, said Roberts belatedly learned that Life Technologies was owned by Thermo Fisher. The letter noted that “the ordinary conflict check conducted in the chief justice’s chamber’s inadvertently failed to find this potential conflict.” Roberts will therefore step aside, meaning only seven of the court’s eight justices will decide the case, which was argued on Dec. 6. Roberts’ 1,212 shares are worth around $175,000 based on the current share price of around $145. Supreme Court justices routinely recuse themselves in cases involving companies in which they own stocks, but each conducts its own checks for potential conflicts. In 2015, Justice Stephen Breyer belatedly spotted a similar stock conflict in an energy case, but instead of recusing, he decided to sell off the stock to cure the conflict before continuing to work on the case. Gabe Roth, the executive director of Fix the Court, a court watchdog that has called for justices to implement better conflict checks, seemed to note a pattern. “This is the third instance in the last 15 months in which a justice initially missed a stock conflict and failed to recuse himself from a case as required by law,” Roth said in a statement. “Why is it so hard for the Supreme Court to get this right?” HuffPost contributed to this report. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

Выбор редакции
05 января, 04:08

Chief Justice Roberts Will Sit Out Patent Case Over $175,000 Stock Conflict

WASHINGTON ― Chief Justice John Roberts will no longer participate in a patent dispute at the Supreme Court involving a unit of Thermo Fisher Scientific Inc., after he realized he owns about $175,000 of stock in the company, the court said on Wednesday. The eight-justice court is weighing whether genetic-testing kits made by Thermo Fisher-owned Life Technologies Corp infringed upon patents held by Promega Corp. In a letter issued on Wednesday, Scott Harris, the clerk of the court, said Roberts belatedly learned that Life Technologies was owned by Thermo Fisher. The letter noted that “the ordinary conflict check conducted in the chief justice’s chamber’s inadvertently failed to find this potential conflict.” Roberts will therefore step aside, meaning only seven of the court’s eight justices will decide the case, which was argued on Dec. 6. Roberts’ 1,212 shares are worth around $175,000 based on the current share price of around $145. Supreme Court justices routinely recuse themselves in cases involving companies in which they own stocks, but each conducts its own checks for potential conflicts. In 2015, Justice Stephen Breyer belatedly spotted a similar stock conflict in an energy case, but instead of recusing, he decided to sell off the stock to cure the conflict before continuing to work on the case. Gabe Roth, the executive director of Fix the Court, a court watchdog that has called for justices to implement better conflict checks, seemed to note a pattern. “This is the third instance in the last 15 months in which a justice initially missed a stock conflict and failed to recuse himself from a case as required by law,” Roth said in a statement. “Why is it so hard for the Supreme Court to get this right?” HuffPost contributed to this report. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

Выбор редакции
15 декабря 2016, 01:16

Top Research Reports for Today: BMY, RDS.A, FB

Top Research Reports for Today: BMY, RDS.A, FB

13 декабря 2016, 17:30

Zacks.com featured highlights: Arch Capital Group, NICE, First American Financial, Silicon Motion Technology and Thermo Fisher Scientific

Zacks.com featured highlights: Arch Capital Group, NICE, First American Financial, Silicon Motion Technology and Thermo Fisher Scientific

12 декабря 2016, 15:23

5 GARP Stocks that Should Grace Your Portfolio

Growth at a reasonable price or GARP is speculated to offer investors a chance to get hold of stocks that are undervalued but have impressive growth potential.

05 декабря 2016, 17:30

Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Zimmer Biomet and Nxstage Medical

Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Zimmer Biomet and Nxstage Medical

02 декабря 2016, 22:46

MedTech Sails Through Macro Woes: Stocks in Focus

MedTech Sails Through Macro Woes: Stocks in Focus

01 декабря 2016, 19:13

Блютанг остается проблемой для Европы

Блютанг остается проблемой для Европы 01.12.2016 Вирус блютанга продолжает оставаться проблемой для Европы, во Франции было отмечено более 90 вспышек заболевания в течение последних нескольких недель, сообщила Сандрин Мойн, кандидат наук, специалист компании Thermo Fisher Scientific. "Диагностика в этом вопросе играет ключевую роль, помогая установить зоны ограничения болезни, зафиксированной в настоящее время в 14 странах ЕС", - отмечает д-р Мойн...Сегодня многие европейские страны создают программы наблюдения и управления, для помощи ветеринарам и фермерам в борьбе с блютангом.(http://www.korovainfo.ru/...)

28 ноября 2016, 17:30

Zacks.com featured highlights: First American Financial, AngioDynamics, Microsemi, Thermo Fisher Scientific and F5 Networks

Zacks.com featured highlights: First American Financial, AngioDynamics, Microsemi, Thermo Fisher Scientific and F5 Networks